216 related articles for article (PubMed ID: 25503919)
41. Pneumococcal conjugate vaccine: a newer vaccine available in India.
Verma R; Khanna P
Hum Vaccin Immunother; 2012 Sep; 8(9):1317-20. PubMed ID: 22894967
[TBL] [Abstract][Full Text] [Related]
42. Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?
Hanquet G; Perrocheau A; Kissling E; Bruhl DL; Tarragó D; Stuart J; Stefanoff P; Heuberger S; Kriz P; Vergison A; de Greeff SC; Amato-Gauci A; Celentano LP;
Vaccine; 2010 May; 28(23):3920-8. PubMed ID: 20394721
[TBL] [Abstract][Full Text] [Related]
43. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
[TBL] [Abstract][Full Text] [Related]
44. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
[TBL] [Abstract][Full Text] [Related]
45. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Hsu KK; Shea KM; Stevenson AE; Pelton SI;
Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
[TBL] [Abstract][Full Text] [Related]
46. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
47. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008.
von Gottberg A; Cohen C; de Gouveia L; Meiring S; Quan V; Whitelaw A; Crowther-Gibson P; Madhi SA; Whitney CG; Klugman KP
Vaccine; 2013 Aug; 31(38):4200-8. PubMed ID: 23684826
[TBL] [Abstract][Full Text] [Related]
48. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
Singh J; Sundaresan S; Manoharan A; Shet A
Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
[TBL] [Abstract][Full Text] [Related]
49. Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes.
Molander V; Elisson C; Balaji V; Backhaus E; John J; Vargheese R; Jayaraman R; Andersson R
BMC Infect Dis; 2013 Nov; 13():532. PubMed ID: 24206667
[TBL] [Abstract][Full Text] [Related]
50. Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya.
Flasche S; Ojal J; Le Polain de Waroux O; Otiende M; O'Brien KL; Kiti M; Nokes DJ; Edmunds WJ; Scott JAG
BMC Med; 2017 Jun; 15(1):113. PubMed ID: 28592303
[TBL] [Abstract][Full Text] [Related]
51. Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study.
Ouldali N; Varon E; Levy C; Angoulvant F; Georges S; Ploy MC; Kempf M; Cremniter J; Cohen R; Bruhl DL; Danis K
Lancet Infect Dis; 2021 Jan; 21(1):137-147. PubMed ID: 32702302
[TBL] [Abstract][Full Text] [Related]
52. Estimated Annual Health and Cost Impact of PHiD-CV Immunization Program in Brazil.
Gomez JA; Lopes de Abreu AJ; Caceres DC; Nieto J; Ortega-Barria E
Pediatr Infect Dis J; 2019 Oct; 38(10):e260-e265. PubMed ID: 31568144
[TBL] [Abstract][Full Text] [Related]
53. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
54. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
[TBL] [Abstract][Full Text] [Related]
55. Impact of Childhood Pneumococcal Conjugate Vaccine on Nonnotified Clinically Suspected Invasive Pneumococcal Disease in Australia.
Gidding HF; Sheridan S; Fathima P; Moore HC; Liu B; McIntyre PB; Palmu AA;
Pediatr Infect Dis J; 2019 Aug; 38(8):860-865. PubMed ID: 30985507
[TBL] [Abstract][Full Text] [Related]
56. Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
Richter L; Schmid D; Kanitz EE; Zwazl I; Pöllabauer E; Jasinska J; Burgmann H; Kundi M; Wiedermann U
PLoS One; 2019; 14(1):e0210081. PubMed ID: 30629620
[TBL] [Abstract][Full Text] [Related]
57. Ten years of experience with the pneumococcal non-typeable
Lecrenier N; Marijam A; Olbrecht J; Soumahoro L; Nieto Guevara J; Mungall B
Expert Rev Vaccines; 2020 Mar; 19(3):247-265. PubMed ID: 32195602
[No Abstract] [Full Text] [Related]
58. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.
O'Brien KL; Wolfson LJ; Watt JP; Henkle E; Deloria-Knoll M; McCall N; Lee E; Mulholland K; Levine OS; Cherian T;
Lancet; 2009 Sep; 374(9693):893-902. PubMed ID: 19748398
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned.
La Vincente SF; von Mollendorf C; Ulziibayar M; Satzke C; Dashtseren L; Fox KK; Dunne EM; Nguyen CD; de Campo J; de Campo M; Thomson H; Surenkhand G; Demberelsuren S; Bujinlkham S; Do LAH; Narangerel D; Cherian T; Mungun T; Mulholland EK
BMC Public Health; 2019 Mar; 19(1):333. PubMed ID: 30898094
[TBL] [Abstract][Full Text] [Related]
60. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
